Almost a quarter of pediatric patients with acute lymphoblastic leukemia (ALL) suffer from relapses. The biological mechanisms underlying therapy response and development of relapses have remained ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback